Wednesday, January 25, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home CBRNE

RFI – Chemical Agent Fate Modeling

by Global Biodefense Staff
March 27, 2015
CBRN Decontamination Tech Evaluations

The Defense Threat Reduction Agency (DTRA) Chemical and Biological Technologies section is seeking information from respondents who possess the capability to address modeling and simulation of contact hazard and long-term environmental fate of chemical agents.

Focus areas of this effort include:

  • Increased fidelity of the current Droplet Reaction and Evaporation of Agents Model (DREAM V2 model) by development and demonstration of a complete set of models for characterizing chemical agent fate of both traditional and non-traditional chemical warfare agents, including long term environmental response and evaporative/contact hazards.
  • Incorporation of additional non-traditional agent (NTA) data into the Defense Technology Objective (DTO) Environmental Fate of Agents database.
  • Completion of verification and validation of the DREAM V2 model for droplet contact angle and spread against experimental data for two high priority NTAs to demonstrate that the framework developed to model agent fate of traditional agents will also work for non-traditional agents.
  • Full integration of the DREAM V2 module into the Joint Effects Model S&T Prototype/Hazard Prediction and Assessment Capability (JSTP/HPAC) and the Joint Effects Model (JEM), including developing interfaces such that DREAM V2 is compliant with the Common CBRN Modeling Interface (CCMI).

Respondents are requested to submit capability statements which include a description of their ability to maintain labor categories possessing minimum SECRET-level security clearances to support a program of this nature.

Further details are available via Solicitation Number: RFIJ9CBIAF. The response deadline is April 1, 2015.

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
two soldiers are in head-to-toe hazmat suits with respirator masks while tending to a mannikin on a stretcher
CBRNE

Protection from Biothreats: DOD to Modernize Medical Countermeasures Development

January 10, 2023
Killing Anthrax More Quickly with Hot Air Decontamination
CBRNE

Killing Anthrax More Quickly with Hot Air Decontamination

January 4, 2023
New Material Helps Train First Responders on Biothreats
Biodetection

New Material Helps Train First Responders on Biothreats

January 4, 2023
Load More

Latest News

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023

Biodefense Headlines – 17 January 2023

January 17, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC